Is Glypican-3 useful Diagnostic Marker that Distinguishes Hepatocellular Carcinoma from Liver Cirrhosis?

EXPRESSION OF GLYPICAN-3(GPC-3) AND 8-HYDROXYDEOXYGUANOSINE (8-OHDG) IN CHRONIC HEPATITIS C AND RELATIONSHIP WITH HEPATOCELLULAR CARCINOMA

A STUDY OF GLYPICAN 3 LEVELS IN PATIENTS OF HEPATO-CELLULAR CARCINOMA

Study of Glypican-3 in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma

Study of Serum Golgi Protein 73 Level as a Marker for Diagnosis of Hepatocellular Carcinoma

Hepatocellular Carcinoma Detection in Hepatitis C Virus-Related Cirrhosis by Glypican-3

PREDICTIVE AND DIAGNOSTIC ROLE OF CIRCULATING GOLGI PROTEIN-73 AND GLYPICAN-3 PROTEIN FOR CHRONIC VIRAL HEPATITIS ASSOCIATED HEPATOCELLULAR CARCINOMA

EVALUATION OF DES-GAMMA CARBOXY PROTHROMBIN AS A BIOMARKER FOR EARLY DETECTION OF HEPATOCELLULAR CARCINOMA ON TOP OF CHRONIC ACTIVE HEPATITIS POST VIRUS C INFECTION

Evaluation of squamous cell carcinoma antigen-immunoglobulin M (SCCA-IGM) & alpha-l-fucosidase as novel biomarkers for diagnosing hepatocellular carcinoma

ROLE OF SERUM GLYPICAN-3 (GPC-3) IN EARLY DETECTION OF HEPATOCELLULAR CARCENOMA